Effects of orally administered ritodrine on carbohydrate and lipid metabolism in pregnant patients with abnormal glucose tolerance.
Biol Res Pregnancy Perinatol
; 5(1): 42-6, 1984.
Article
en En
| MEDLINE
| ID: mdl-6367841
ABSTRACT
The metabolic effects of a widely used betamimetic agent (ritodrine) were studied in two groups of pregnant patients with abnormal glucose tolerance. No significance modification of various metabolic parameters was detected when the drug was orally administered in standard doses for at least 1 week. The possible reasons for this finding are discussed. Following the absence of any diabetogenic effect, a prolonged use of betamimetics to achieve tocolysis seems to be safe even in patients with metabolic disorders.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Embarazo en Diabéticas
/
Propanolaminas
/
Ritodrina
/
Metabolismo de los Hidratos de Carbono
/
Metabolismo de los Lípidos
Límite:
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
Biol Res Pregnancy Perinatol
Año:
1984
Tipo del documento:
Article